Most Popular White Papers
Health Care Industry
Industry: Email Alert RSS FeedADEC recommendations: Bone drug combo up for listing.
Australian Doctor, November, 2005
 | Content provided in partnership with |  |
by Bianca Nogrady
A COMBINATION of a bisphosphonate and cholecalciferol has been recommended for listing at the latest Australian Drug Evaluation Committee meeting.
The drug combines 70mg alendronic acid with 70A[micro]g cholecalciferol (Fosamax Plus Once Weekly) and represents the first combination in Australia recommended for the treatment of osteoporosis in patients who are also vitamin D deficient.
ADEC also recommended approval of a new vaccine against ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Business
- Academy of Marketing Science Review
- Accounting Historians Journal, The
- Accounting History
- AgExporter
- Agricultural Research
- Agricultural and Resource Economics Review
- Air Force Comptroller
- Air Safety Week
- Airline Industry Information
- American Demographics
- American Journal of Potato Research
- Architectural Review, The
- Asian Economic News
- Entrepreneur
Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »